| Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome. | |
| | |
MedLine Citation:
|
PMID: 20440736 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To investigate the associations between four defined adverse pregnancy outcomes and levels of first and second trimester maternal serum markers focusing in particular on how well combinations of markers predict these adverse outcomes. METHODS: This was a retrospective review of associations between first and second trimester serum markers and adverse pregnancy outcomes among 141 698 women who underwent prenatal screening for Down syndrome in Ontario, Canada. Detection rates (DR), false positive rates (FPR), and odds ratios were estimated using both single and combinations of markers for the adverse outcomes defined. RESULTS: Women with decreased second trimester unconjugated oestriol (uE3), deceased first trimester maternal serum pregnancy-associated plasma protein A (PAPP-A), increased second trimester serum alpha fetoprotein (AFP), or increased second trimester total human chorionic gonadotrophin (hCG) were at greater risk of developing adverse pregnancy outcomes. At a 5% FPR, combinations of these markers predicted at best 33.3% of fetal loss and 31.5% of preterm births (PTB) before 32 weeks of gestation. CONCLUSION: There are significant associations between the levels of first and second trimester serum markers and adverse obstetric outcomes. However, even combinations of these markers can only predict adverse obstetric outcomes with modest accuracy. |
| | |
Authors:
|
Tianhua Huang; Barry Hoffman; Wendy Meschino; John Kingdom; Nanette Okun |
Related Documents
:
|
11928766 - Triploid pregnancy detected incidentally by down's syndrome screening. 12948096 - First-trimester screening for down syndrome in singleton pregnancies achieved by intrau... 12694966 - Detection of fetal rhesus d gene in whole blood of women booking for routine antenatal ... 10451516 - Comparison of nuchal translucency measurement and second-trimester triple serum screeni... 12808166 - Predicted creatinine clearance to evaluate glomerular filtration rate in black caribbea... 6886096 - Acrodermatitis enteropathica. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Prenatal diagnosis Volume: 30 ISSN: 1097-0223 ISO Abbreviation: Prenat. Diagn. Publication Date: 2010 May |
Date Detail:
|
Created Date: 2010-05-04 Completed Date: 2010-09-13 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8106540 Medline TA: Prenat Diagn Country: England |
Other Details:
|
Languages: eng Pagination: 471-7 Citation Subset: IM |
Affiliation:
|
Genetics Program, North York General Hospital, Ontario, Canada. thuang@nygh.on.ca |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Biological Markers / blood Chorionic Gonadotropin / blood Down Syndrome / blood Estriol / blood False Positive Reactions Female Fetal Death / blood* Humans Pre-Eclampsia / blood* Predictive Value of Tests Pregnancy Pregnancy Trimester, First / blood* Pregnancy Trimester, Second / blood* Pregnancy-Associated Plasma Protein-A / analysis Premature Birth / blood* ROC Curve Retrospective Studies alpha-Fetoproteins / analysis |
| Chemical | |
Reg. No./Substance:
|
0/Biological Markers; 0/Chorionic Gonadotropin; 0/alpha-Fetoproteins; 50-27-1/Estriol; EC 3.4.24.-/Pregnancy-Associated Plasma Protein-A |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Training in cordocentesis: the first 50 case experience with and without a cordocentesis training mo...
Next Document: Postmarital follow-up survey on high risk patients subjected to premarital screening program in Saud...